Epigral Limited

Held by 9 funds in our universe · avg weight 0.44% · range 0.01% to 0.88%

Fundamentals

Current price ₹895.0

Market cap ₹4,313 cr

P/E (TTM) 15.9

P/B 1.9

ROE 14.9%

Debt / equity 25.75

Revenue growth +16.3%

Profit margin 10.3%

Dividend yield 0.50%

P/E history band: 11-22 · currently mid-range

Technicals · split/bonus-adjusted

From 52-wk high -47.5%

52-week high ₹1706.5

52-week low ₹810.5

200-day MA ₹1084.0

vs 200D MA -17.4%

Worst drop 3y -65.4%

Worst drop all-time -65.4%

Market-cap class Small Cap

Price as of 2026-10-23

Funds by category

All (9) Equity – Sectoral/ Thematic (2) Equity – Focused Fund (1) Equity – Value Fund (1) Equity – Small Cap Fund (1) Equity – ELSS (1) Equity – Multi Cap Fund (1) Equity – Flexi Cap Fund (1) Other – Index Funds (1)

Showing only Equity – ELSS funds. clear filter

1 Equity – ELSS fund holding this stock , sorted by the stock's weight in each fund

Fund	Category	% of fund in this stock	As of
HSBC ELSS Tax saver Fund - Direct Plan - Growth HSBC Mutual Fund	Equity · ELSS	0.29%	2026-06-30

Holdings sourced from scheme portfolios as published by their AMCs each month under SEBI rules. "% of fund in this stock" is the position weight inside each fund, NOT the rupee value of any individual investor's exposure.